-
Product Insights
NewLikelihood of Approval Analysis for Trypanosomiasis
Overview How likely is it that the drugs in Trypanosomiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trypanosomiasis Overview Trypanosomiasis, also known as sleeping sickness in humans and nagana in...
-
Product Insights
NewLikelihood of Approval Analysis for Rabies
Overview How likely is it that the drugs in Rabies will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rabies Overview Rabies is a deadly virus spread to people from the saliva...
-
Product Insights
NewLikelihood of Approval Analysis for Vulvovaginal Candidiasis
Overview How likely is it that the drugs in Vulvovaginal Candidiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vulvovaginal Candidiasis Overview An excessive growth of yeast in the vagina that...
-
Product Insights
NewLikelihood of Approval Analysis for Lyme Disease
Overview How likely is it that the drugs in Lyme Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lyme Disease Overview Lyme disease is a bacterial infection transmitted by a...
-
Product Insights
NewLikelihood of Approval Analysis for Neurofibromatoses Type I (Von Recklinghausen’s Disease)
Overview How likely is it that the drugs in Neurofibromatoses Type I (Von Recklinghausen's Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neurofibromatoses Type I (Von Recklinghausen's Disease) Overview Neurofibromatosis...
-
Product Insights
NewLikelihood of Approval Analysis for Lyssavirus infections
Overview How likely is it that the drugs in Lyssavirus infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lyssavirus infections Overview The infections caused by a group of lyssaviruses are...
-
Product Insights
NewLikelihood of Approval Analysis for Malaria
Overview How likely is it that the drugs in Malaria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malaria Overview Malaria is a life-threatening blood disease caused by a parasite (Plasmodium)...
-
Product Insights
NewLikelihood of Approval Analysis for Herpesviridae Infections
Overview How likely is it that the drugs in Herpesviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Herpesviridae Infections Overview The infections caused by Herpesviridae viruses are called Herpesviridae...
-
Product Insights
NewLikelihood of Approval Analysis for Axillary Hyperhidrosis
Overview How likely is it that the drugs in Axillary Hyperhidrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axillary Hyperhidrosis Overview Axillary hyperhidrosis also referred to as excessive underarm sweating....
-
Product Insights
NewLikelihood of Approval Analysis for Clostridium tetani Infections
Overview How likely is it that the drugs in Clostridium tetani Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Clostridium tetani Infections Overview Clostridium tetani infections are a serious disease...